Frontlight ResearchEarly access
Graves' disease trials in New Zealand
2 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Auckland, Wellington
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 1/2Taking peopleA Study of VV-14305 for the Treatment of Thyroid Eye Disease
- Where
- Auckland, Wellington
- Age
- 18 years to 80 years
- People
- 135 worldwide
- Run by
- Kriya Therapeutics, Inc.
See details and how to joinNCT07404111